Drive Wealth Management’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
Other funds holding RDY
AIM
Drive Wealth Management's RDY Position: Q2 2026 in Review
Drive Wealth Management reduced its Dr. Reddy's Laboratories (RDY) stake by 21% in Q2 2026, selling an estimated $45.8K and leaving 12,416 shares worth $180K. The position accounts for 0.03% of the portfolio, ranked #434.
Drive Wealth Management first reported a position in RDY in Q2 2024 and has held it in 9 quarters since. The position peaked at $220K in Q4 2025. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.
- Drive Wealth Management held 12,416 shares of Dr. Reddy's Laboratories worth $180K as of Q2 2026.
- Drive Wealth Management sold 3,396 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $45.8K.
- Dr. Reddy's Laboratories made up 0.03% of Drive Wealth Management's portfolio in Q2 2026, its #434 holding.
- Drive Wealth Management first reported a position in Dr. Reddy's Laboratories in Q2 2024 and has held it in 9 quarters since.
- Drive Wealth Management's Dr. Reddy's Laboratories position peaked at $220K in Q4 2025.
- 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.
Based on Drive Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.